The core activity of Regenosca SA is the development and manufacture of bio-implants, particularly using the TissueSpan technology, which enables the body to attract and organize its own cells after the removal of diseased tissue, allowing for seamless healing.
AI-generated
Offering
Products & services
Industry:Medical Technology Industry
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.